In vivo, Dkk1 inhibition is neuroprotective in a model of temporal lobe epilepsy induced by kainic acid injection [19], [26] and in different models of cerebral ischaemia [19]–[21]. Here, DKK1 is linked to temporal lobe epilepsy.